Just Phase 2 results - 35 patientsI rejigged the latest data (April 29) a little bit. I'm not sure if an Excel cut and paste will work but I'll give it a try. I took just the 35 patients from the phase 2 trial, eliminating 2 CR's (patients 5 & 6 from phase 1) and 1 NR (patient 4 from phase 1) I think things are looking pretty good. There is still a possible CR rate of 63% at 450 days. It all depends on the 450 day assessments of the 17 pending patients (plus a favourable ruling on the 2 PR patients).
| Assessment | Patient Assessment Visit |
| 90 | 180 | 270 | 360 | 450 |
| Complete Response ("CR") | 15 (42.8%) | 12 (34.3%) | 7 (20.0%) | 3 (8.6%) | 3 (8.6%) |
| Partial Response ("PR") | 6 | 6 | 2 | 3 | 2 |
| Pending | 3 | 8 | 15 | 17 | 17 |
| No Response ("NR") | 11 | 9 | 11 | 12 | 13 |
| CR (Evaluable Patients) | 46.90% | 44.40% | 35% | 16.70% | 16.70% |
| CR Potential | 68.60% | 74.30% | 68.60% | 65.70% | 62.80% |
| Patients Treated | 35 | 35 | 35 | 35 | 35 |